Bisphosphonates are synthetic analogues of pyrophosphate that preferentially bind to hydroxyapatite crystals in bone, where they are internalised by osteoclasts during the resorption process.
An updated position statement on the management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer provides the latest evidence-based guidance, with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results